Benefits Of CBD In Women's Health
Cannabinoids are effective in treating a variety of women's health issues, including osteoporosis, menopause symptoms, thyroid problems, fibromyalgia, and breast cancer. The endocannabinoid system's scientific study has ramifications for women's health. Endocannabinoids can be detected in uterine and reproductive system cells, as well as breast milk.
The endocannabinoid system is directly related to the endocrine system, particularly to the relationship between the hypothalamus, the pituitary, and other hormonal regulators, such as the adrenals (called the hypothalamus-pituitary-adrenal axis, or HPA axis).
The pituitary gland regulates several reproductive functions, including the release of the follicle-stimulating hormone (FSH), which triggers ovulation. As the body tries to balance its hormones in a new way in the years leading up to menopause, the release of this hormone may be erratic while it steadily diminishes (once a woman reaches menopause, the pituitary stops producing FSH altogether).
While many traditional medicines used to treat women's health concerns have been kept hidden for millennia, and some have been lost over time, records of the use of cannabis in labor, birth, and the treatment of menstruation diseases extend back to ancient Mesopotamia seven centuries before Christ. Several references to the topical application of cannabis in fat or oil to relieve breast discomfort and prevent mastitis in nursing women can be found in Europe during the Middle Ages.
People used to believe that it increased uterine muscular tone, which reduced extra blood flow during menstruation and after childbirth. It was claimed to operate in tandem with ergot, a substance often used as an abortifacient and to prevent excessive blood loss upon birth (a derivative, Methergine, is still used for this purpose in hospital settings).
Premenstrual syndrome (PMS), endometriosis, and menstrual cramps have all been treated with cannabis in the past. Despite this, scientists have yet to devote significant attention to the potential of cannabis to treat these widespread diseases that impact millions of women.
Premenstrual hormone fluctuations can induce a variety of symptoms, including discomfort, irritation, mood swings, exhaustion, and bloating. Hormone levels such as progesterone rise dramatically during this phase, whereas estrogen levels fall.
Hormonal changes also affect the endometrium, which is the uterus's inner lining. Endometriosis occurs when the cells that make up this lining proliferate outside the uterus, resulting in painful growths and adhesions.
Estrogen and endocannabinoid levels are connected, because both peak during ovulation and decline after menopause. Estrogen regulates FAAH, the enzyme that breaks down and regulates the endocannabinoid anandamide. In fact, activating estrogen and cannabinoid receptors on the same cell might have a synergistic impact, resulting in stronger benefits.
Many women claim comfort from the use of cannabis products due to a reduction in endocannabinoid signaling, which may be responsible for some of the negative symptoms associated with menopause. Cannabinoids were proven to alleviate menopause-related sleeplessness in a 2007 study. Estrogen activates the endocannabinoid system, which helps to regulate emotional responses and alleviate anxiety and depression. Low estrogen levels during and after menopause indicate that the endocannabinoid system is less activated, resulting in a reduced ability to respond to stress and elevate mood. Hot flashes are another symptom that cannabis can help with since it lowers body temperature. Finally, menopause might bring up sex-related difficulties such as changes in desire, lubrication levels, and sensitivity. Although more research into the possible use of cannabis for these sexual health issues is needed, anecdotal data suggests that they may be effective for some women. THC-infused lubricants are already available, and stimulating sativa strains are frequently suggested for boosting sex and increasing drive. Low amounts of endocannabinoids can cause early menopause.
Low endocannabinoid levels are also found in underweight women and women with anorexia who tend to approach menopause early. Because an endocannabinoid shortage can be corrected by supplementing with phytocannabinoids, it is thought that this could help women delay menopause. The endocannabinoid system is in charge of regulating bone loss after menopause. CB2 receptors are located on osteoblasts, which are bone cells. After menopause, a frequent mutation in the CB2 gene, which results in fewer CB2 receptors, has been linked to osteoporosis. The endocannabinoid signaling agent anandamide is responsible for creating bone at the CB1 receptor in bone, whereas 2-AG is responsible for breaking it down at the CB2 receptor, allowing bone to remodel throughout life.
Though it is evident that the endocannabinoid system is closely involved in regulating the chemical messengers important to fertility and lactation, the jury is yet out on the effect of plant-based cannabinoids on pregnancy and the developing baby. There are few studies on the possible dangers of prenatal exposure, and they are often contradictory.
Many of the obstacles to research in this field are related to the difficulties of controlling alcohol and other narcotics, as well as the legal consequences that women may face in some jurisdictions if they admit to using cannabis while pregnant. As a result, much of the research on the prevalence of maternal cannabis use and its health consequences has been limited to historical texts, studies from non-Western countries where cannabis use is more socially acceptable, and retrospective survey data.
Most cannabinoids, including CBD, have not been fully explored in relation to pregnancy. Almost all of the study has focused on THC, and not all of it has adequately controlled the use of alcohol or other drugs. Cannabis' apparent impact on birth weight and other unfavorable prenatal outcomes is low, according to those who do regulate other substances. In animals given massive doses of synthetic THC, however, unfavorable reproductive consequences have been recorded.
While the effects of cannabis on pregnancy and fetal development are still poorly understood by science and remain a matter of debate, women have reported that very tiny doses of cannabis are useful in treating nausea, anxiety, and depression during pregnancy.
Pregnant women and health care providers, on the other hand, should be aware of potential hazards and are urged to use cannabis with caution, avoiding synthetic cannabinoids and high-potency THC products in particular.
There are lots of reasons why women should explore with cannabis. However, studies show that getting the appropriate dosage is critical to obtaining the health benefits. Low dosages appear to be more helpful, while too much cannabis appears to negate the health benefits. Marijuana can be a terrific adjunct to your self-care routine if you stick to your restrictions.